Share
Copied
Medical device companies in northwest China's Xinjiang Uygur Autonomous Region are widening their production lines in response to the optimization of COVID-19 containment measures, with a greater focus on public, rather than institutional demand. Zhang Jie, Manager of Xinjiang Gaoxin Lebel Medical Instrument Co., Ltd told CGTN that upgrading medical products for use by the general public and upgrading its general products to medical grade is among their future goals.
As China downgraded COVID-19 infection management to Class B, down from Class A in late December 2022, do people still need to take protection measures? What are the lessons for medical device companies to take after SARS, Ebola or geological hazards? What are the transformations of medical device supply companies in order to take on the challenge of production and company operation?
Search Trends
SITEMAP
Copyright © 2023 CGTN. 京ICP备16065310号
Disinformation report hotline: 010-85061466
SITEMAP
Copyright © 2023 CGTN. 京ICP备16065310号
Disinformation report hotline: 010-85061466